These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 10641099)

  • 1. [Alpha-2 adrenergic agonists in the treatment of glaucoma].
    Apătăchioae I; Chiseliţă D
    Oftalmologia; 1999; 47(2):35-40. PubMed ID: 10641099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
    Greenfield DS; Liebmann JM; Ritch R
    J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect and side effects of apraclonidine].
    Stewart WC
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):A7-13. PubMed ID: 8965469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brimonidine--an alpha 2-agonist for glaucoma.
    Med Lett Drugs Ther; 1997 Jun; 39(1002):54-5. PubMed ID: 9198727
    [No Abstract]   [Full Text] [Related]  

  • 5. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
    Chen TC
    J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the role of alpha-agonists in glaucoma management.
    Arthur S; Cantor LB
    Exp Eye Res; 2011 Sep; 93(3):271-83. PubMed ID: 21524649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy.
    Yuen NS; Cheung P; Hui SP
    Jpn J Ophthalmol; 2005; 49(2):89-92. PubMed ID: 15838723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of brimonidine 0.2% in treatment of glaucoma or ocular hypertony after poorly tolerated beta-blocker treatment].
    Titouamane S; Baudouin C
    J Fr Ophtalmol; 2002 Jun; 25(6):568-75. PubMed ID: 12223942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of apraclonidine on short-term outcome of glaucoma surgery.
    Azuara-Blanco A; Araujo SV; Lu DW; Lesk MR; Katz LJ; Spaeth GL
    J Glaucoma; 1996 Apr; 5(2):117-9. PubMed ID: 8795743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is brimonidine ophthalmic a safe therapy for infants?
    Daubert GP
    J Clin Pharm Ther; 2006 Jun; 31(3):289-92. PubMed ID: 16789995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys.
    Gabelt BT; Robinson JC; Hubbard WC; Peterson CM; Debink N; Wadhwa A; Kaufman PL
    Exp Eye Res; 1994 Dec; 59(6):633-44. PubMed ID: 7698258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of apraclonidine and brimonidine as aqueous suppressants in humans.
    Schadlu R; Maus TL; Nau CB; Brubaker RF
    Arch Ophthalmol; 1998 Nov; 116(11):1441-4. PubMed ID: 9823343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term brimonidine therapy in glaucoma patients with apraclonidine allergy.
    Shin DH; Glover BK; Cha SC; Kim YY; Kim C; Nguyen KD
    Am J Ophthalmol; 1999 May; 127(5):511-5. PubMed ID: 10334342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
    WoldeMussie E; Ruiz G; Wijono M; Wheeler LA
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2849-55. PubMed ID: 11687528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side-effect profile of brimonidine tartrate in children.
    Al-Shahwan S; Al-Torbak AA; Turkmani S; Al-Omran M; Al-Jadaan I; Edward DP
    Ophthalmology; 2005 Dec; 112(12):2143. PubMed ID: 16225927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacology aspects of glaucoma].
    Alm A; Berggren L
    Nord Med; 1992; 107(12):306-8, 318. PubMed ID: 1361228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brimonidine for glaucoma.
    Rahman MQ; Ramaesh K; Montgomery DM
    Expert Opin Drug Saf; 2010 May; 9(3):483-91. PubMed ID: 20367525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iopidine in the control of intraocular pressure after glaucoma laser treatment].
    Stîngu C; Cristescu A; Dărăban C; Ioniţă M; Serghiescu S
    Oftalmologia; 2001; 54(4):32-5. PubMed ID: 12035597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of topical clonidine versus brimonidine on choroidal blood flow and intraocular pressure during squatting.
    Weigert G; Resch H; Garhofer G; Fuchsjäger-Mayrl G; Schmetterer L
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4220-5. PubMed ID: 17724210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.